The immunopathology of ANCA-associated vasculitis

• Main Authors: McKinney, E.F, Willcocks, L.C, Broecker, V, Smith, K.G.C
• Other Authors: MEDICINE
• Format: Review
• Published: 2020
• Subjects: complement component C5a; cyclophosphamide; enzyme antibody; immunosuppressive agent; lysosome associated membrane protein 2; myeloblastin; myeloperoxidase antibody; neutrophil cytoplasmic antibody; rituximab; T lymphocyte receptor; unclassified drug; ANCA associated vasculitis; antibody titer; antigen antibody reaction; CD4+ T lymphocyte; CD8+ T lymphocyte; clinical feature; complement system; copy number variation; disease classification; genetic association; genetic risk; histopathology; human; immunopathology; immunosuppressive treatment; in vivo study; lymphocyte function; lymphocytic infiltration; major histocompatibility complex; nonhuman; prevalence; priority journal; relapse; review; single nucleotide polymorphism; treatment outcome; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; classification; immunology; pathology; syndrome; Antibodies, Antineutrophil Cytoplasmic; Humans; Syndrome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/181779
• Institution: National University of Singapore

10.1007/s00281-014-0436-6